Live Breaking News & Updates on Vesper Point

Stay updated with breaking news from Vesper point. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Vesper (VSP) Hits 1-Day Volume of $135,612.00

Vesper (VSP) traded up 2.8% against the dollar during the 1-day period ending at 14:00 PM Eastern on March 22nd. One Vesper coin can now be purchased for about $2.13 or 0.00004999 BTC on cryptocurrency exchanges. During the last seven days, Vesper has traded 23.9% higher against the dollar. Vesper has a market cap of […] ....

Shiba Inu , Vesper Community , Decentralized Finance , Vesper Products , Vesper Grow Pools , Currency Vesper ,

Vesper Reaches Market Capitalization of $16.47 Million (VSP)

Vesper (CURRENCY:VSP) traded 2.1% lower against the US dollar during the one day period ending at 15:00 PM Eastern on March 10th. Vesper has a total market capitalization of $16.47 million and approximately $172,467.00 worth of Vesper was traded on exchanges in the last 24 hours. One Vesper coin can now be purchased for $1.91 […] ....

Shiba Inu , Vesper Community , Decentralized Finance , Vesper Products , Vesper Grow Pools , Currency Vesper ,

Acte responsable a l'Institut del Teatre

L escàndol va saltar el març a l Institut del Teatre. Les denúncies semblaven no tenir fons. L Institut del Teatre, entitat referent de les arts escèniques, era tot un vesper. Al maig, es va. ....

High School Of Theater , High School Of Theater It , High School , Director Magda , உயர் பள்ளி ,

Welcome To IANS Live - LatestNews - Kerala firm successfully completes Phase 2 trials of Covid drug


Photo Credit: IANS
IANSLive
Kochi, Feb 11 (IANS) PNB Vesper, a leading Kerala-based life sciences company, on Thursday announced that it has successfully completed the Phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on Covid-19 patients.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 11-February-2021 ....

News Service , India Private , All Rights , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,

Welcome To IANS Live - NATION - Kerala firm successfully completes Phase 2 trials of Covid drug


Photo Credit: IANS
IANSLive
Kochi, Feb 11 (IANS) PNB Vesper, a leading Kerala-based life sciences company, on Thursday announced that it has successfully completed the Phase 2 clinical trials of its proprietary drug PNB-001 (GPP-Baladol) on Covid-19 patients.
To get full access of the story, click here to subscribe to IANS News Service
© 2021 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.
For news, views and gossips, follow IANS at Twitter.
Update: 11-February-2021 ....

News Service , India Private , All Rights , செய்தி சேவை , இந்தியா ப்ரைவேட் , அனைத்தும் உரிமைகள் ,